MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202628023133 A) filed by Cyclolab Cyclodextrin Research And Development on February 26, 2026, for Cyclodextrin Derivatives In The Treatment Or Prevention Of Lysosomal Neurodegenerative Diseases.
Inventors include Pusks, Istvn; and Kurkayev, Abdula.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: ABSTRACT CYCLODEXTRIN DERIVATIVES IN THE TREATMENT OR PREVENTION OF LYSOSOMAL NEURODEGENERATIVE DISEASES The present invention generally relates to use of single isomer chemically modified cyclodextrins, namely, S-(carboxyalkyl)thio-cyclodextrin salts in medication used for the prevention or treatment of lysosomal storage diseases. More particularly, the present invention relates to isomer-pure, single isomer hexakis-S-(carboxyalkyl)hexathio- alpha-cyclodextrin sodium salts, heptakis-S-(carboxyalkyl)heptathio-beta-cyclodextrin sodium salts and octakis-S-(carboxyalkyl)octathio-gamma-cyclodextrin sodium salts in medication used for the prevention or treatment of lysosomal storage diseases
Disclaimer: Curated by HT Syndication.
